Implementing tobacco use treatment in HIV clinics in Viet Nam

在越南艾滋病毒诊所实施烟草使用治疗

基本信息

批准号：
10854280
负责人：
Nam Truong Nguyen
金额：
$ 18.35万
依托单位：
NEW YORK UNIVERSITY
依托单位国家：
美国
项目类别：
财政年份：
2020
资助国家：
美国
起止时间：
2020-05-01 至 2025-04-30
项目状态：
未结题

来源：
https://reporter.nih.gov/project-details/10854280
关键词：
Abstinence Attitude Behavioral Belief Cancer Control Cancer Etiology Cancer Patient Cessation of life Clinic Communities Consultations Development Dimensions Economics Emotions Evaluation Face Foundations Funding Future Generations Goals Guilt HIV Health Personnel Health care facility High-Risk Cancer Income Individual Influentials Intervention Interview Investigation Knowledge Life Malignant Neoplasms Malignant neoplasm of lung Measures Mental disorders Outcome Patients Persons Policies Populations at Risk Procedures Process Productivity Property Provider Psychometrics Psychosocial Factor Research Rights Risk Role Self Disclosure Shame Shapes Smoking Social Values Stereotyping Stigmatization Testing Tobacco Use Cessation Tobacco use Tobacco-Related Carcinoma Validation Validity and Reliability Vietnam Vietnamese arm cancer care cancer prevention cancer risk cognitive testing compare effectiveness design discount effectiveness-implementation RCT experience health administration high risk insight interest low and middle-income countries mortality peer prevent professional atmosphere psychosocial response screening social social exclusion social stigma

项目摘要

ABSTRACT This application is being submitted in response to the Notice of Special Interest (NOSI) identified as NOT-CA-23-036. Cancer stigma among healthcare providers (HCPs) can impede and decrease the effective delivery and quality of cancer care, particularly in low-and-middle income country (LMIC) settings. Accurate, culturally-adapted assessments of cancer stigma in LMICs among HCP’s, who have been understudied to date, can thus inform efforts to mitigate this key barrier and contribute to clinicians’ efforts to effectively control and prevent cancer in these settings. The supplemental study, which is integrated into a three-arm tobacco cessation implementation-effectiveness randomized control trial among PLWH in Viet Nam, will develop a multi-component cancer stigma scale for clinicians (MCCSS-C), with an additional focus on lung cancer, for use among clinicians who treat patients who are at risk for cancer, and examine how cancer stigma is correlated with psychosocial and behavioral factors. First, a qualitative investigation will be conducted to understand how cancer stigma—and specifically lung cancer stigma—manifests among clinicians who treat patients who are at risk for cancer to inform the development of a cancer stigma measure for HCPs in Viet Nam. In this investigation, HCP’s attitudes and beliefs towards cancer patients (as well as those of their peer co-workers’) will be used to inductively identify new clinician domains of stigma towards people with cancer, with the main objective of exploring how the different components of HCP cancer stigma (i.e., perceived community stigma, negative attitudes and emotions, enacted co-worker stigma, and health facility policies/work environment) are perceived among Vietnamese HCP’s. Following selection of the final items to comprise each dimension-specific stigma subscale, the MCCSS-C will undergo initial psychometric evaluation. The revised MCCSS-C (both the “general cancer stigma” and “lung cancer stigma” versions) will be administered to 30 new HCPs to assess both its initial psychometric properties and the relationships between different cancer stigma dimensions and select psychosocial factors. Little is known about how cancer stigma may manifest in HCPs whose patients are at higher risk of developing cancer, specifically in LMICs, and key insights into this harmful social dynamic along with culturally-salient expressions of stigma will be elucidated in the process of developing our measure. An evaluation of cancer stigma among clinicians who treat people with HIV will act as a key step towards developing a future scale that will generalize to all clinicians in Vietnam and have applicability to clinicians in LMICs overall.

抽象的本申请是为了响应特殊利益通知（NOSI）而提交的，该通知被确定为 NOT-CA-23-036。医疗保健提供者 (HCP) 中的癌症耻辱可能会阻碍并降低有效性。癌症护理的提供和质量，特别是在中低收入国家 (LMIC) 环境中。对中低收入国家 HCP 中的癌症耻辱感进行文化适应评估，他们已接受过充分研究因此，可以为减轻这一关键障碍的努力提供信息，并有助于忠诚者有效控制的努力并在这些环境中预防癌症。这项补充研究被整合到三臂烟草中。越南 PLWH 中戒烟实施效果随机对照试验将制定一项教区居民多成分癌症耻辱量表 (MCCSS-C)，特别关注肺癌，在治疗有癌症风险的患者中使用，并检查癌症耻辱感如何首先，将进行定性调查以了解心理社会和行为因素。了解癌症耻辱感，特别是肺癌耻辱感，如何在接受治疗的信徒中体现出来有患癌症风险的患者告知越南 HCP 癌症耻辱措施的制定 Nam 在这项调查中，了解了 HCP 对癌症患者（及其同伴）的态度和信念。同事的）将被用来归纳识别临床医生对癌症患者的耻辱的新领域，主要目的是探索 HCP 癌症耻辱感的不同组成部分（即感知社区耻辱、消极态度和情绪、制定的同事耻辱以及医疗机构政策/工作在选择了构成每个项目的最终项目后，越南 HCP 对其进行了感知。维度特定的耻辱子量表，MCCSS-C 将接受初步心理测量评估。 MCCSS-C（“一般癌症耻辱”和“肺癌耻辱”版本）将给予 30 名新患者 HCP 评估其初始心理测量特性以及不同癌症耻辱感之间的关系关于癌症耻辱如何在 HCP 中表现出来，我们知之甚少。其患者患癌症的风险较高，特别是在中低收入国家，以及对这种有害疾病的关键见解社会动态和污名的文化显着表达将在这一过程中得到阐明制定我们的措施，评估治疗艾滋病毒感染者的教区居民的癌症耻辱感。这是制定未来量表的关键一步，该量表将推广到越南所有奉献者，并已对中低收入国家人群的整体适用性。

项目成果

期刊论文数量（2）

专著数量（0）

科研奖励数量（0）

会议论文数量（0）

专利数量（0）

Depression and associated factors among HIV-positive smokers receiving care at HIV outpatient clinics in Vietnam: a cross-sectional analysis.

在越南艾滋病毒门诊接受护理的艾滋病毒阳性吸烟者的抑郁症及相关因素：横断面分析。

DOI：
发表时间：
2024-02-13
期刊：
影响因子：
2.9
作者：
Nguyen, Nam Truong;Nguyen, Trang;Vu, Giap Van;Truong, Nga;Pham, Yen;Guevara Alvarez, Gloria;Armstrong;Shelley, Donna
通讯作者：
Shelley, Donna

Adapting a tobacco cessation treatment intervention and implementation strategies to enhance implementation effectiveness and clinical outcomes in the context of HIV care in Vietnam: a case study.

调整戒烟治疗干预措施和实施策略，以提高越南艾滋病毒护理背景下的实施有效性和临床结果：案例研究。

DOI：
发表时间：
2022-10-17
期刊：
影响因子：
0
作者：
Shelley, Donna;Alvarez, Gloria Guevara;Nguyen, Trang;Nguyen, Nam;Goldsamt, Lloyd;Cleland, Charles;Tozan, Yesim;Shuter, Jonathan;Armstrong
通讯作者：
Armstrong